mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.09 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.09 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.1 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |